January 3, 2019
When astronauts spend time in the low-gravity environment of space, they rapidly lose bone, muscle and immune function — all of which happens commonly but slowly with age here on Earth. Equally intriguing, these changes reverse when the astronauts return to Earth. Microgravity thus provides a unique environment that could help us understand and develop new treatments for diseases of aging. Latest Director’s Message >
NCATS Announces Joni Rutter as New Deputy Director
Joni Rutter, Ph.D., will join NCATS as the new deputy director on Jan. 20, 2019. Rutter will be responsible for planning, executing and assessing the Center’s complex and multifaceted pre-clinical and clinical programs and will be a key national spokesperson for translational science. Read the full announcement.
A Model for Accelerating Translational Research in Real Time
Investigators at the Medical College of Wisconsin’s Clinical and Translational Science Awards Program hub have devised and piloted an innovative approach called “Real-Time IRB.” The aim is to reduce the time between study submission to the institutional review board and final approval by 70 percent. Learn more about this work.
NCATS Researchers Develop New Approach to Identify Potential Cancer Drugs
NCATS researchers overcame a translational roadblock by developing tests to identify compounds that disrupt a driver of several cancers. Their work, which involved using NCATS’ high-throughput screening technology to evaluate thousands of compounds at once, provides a template for other scientists to discover new compounds that could be useful as therapies. Learn more about this advance.
NCATS Announces New NIH HEAL Opportunities
NCATS is supporting three new funding opportunities and a prize challenge through the NIH HEAL (Helping to End Addiction Long-termSM) Initiative. All are designed to solicit the best and brightest ideas to bolster existing research in the areas of addiction, pain and opioid use disorders. Read the full announcement.
Meet More NCATS Staff
Xin Xu, Ph.D., is a senior scientist and the director of pharmacokinetics in the Therapeutics Development Branch of NCATS’ Division of Pre-Clinical Innovation. Stephen G. Seidel is deputy director of the Policy Branch of NCATS’ Office of Policy, Communications and Education.
Learn more about these and other staff members >